<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04451473</url>
  </required_header>
  <id_info>
    <org_study_id>ERAS ZYP</org_study_id>
    <nct_id>NCT04451473</nct_id>
  </id_info>
  <brief_title>Lung Surgery With Enhanced Recovery VS. Lung Surgery Without Enhanced Recovery</brief_title>
  <official_title>The Short Term and Long Term Comparison of Lung Surgery With or Without Enhanced Recovery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Second Hospital of Shandong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Second Hospital of Shandong University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: The adoption of Enhanced Recovery Surgery programs in lung resection is relatively
      recent with limited outcome data. This study aimed to determine the impact of an Enhanced
      Recovery Surgery pathway on short- term and long- term results in patients undergoing lung
      resection for primary lung cancer.

      Methods: A Randomized Controlled Trial was designed to collect the perioperative data on
      consecutive patients undergoing lung resection for primary lung cancer. Patients will be
      randomizely assigned to the ERAS- Group and Control- Group. Short-term and long- term effect
      will be compared between the two groups.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 21, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2027</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intensive care unit utilization</measure>
    <time_frame>within 4 days after surgery</time_frame>
    <description>the time in intensive care unit utilization</description>
  </primary_outcome>
  <primary_outcome>
    <measure>the degree of pain</measure>
    <time_frame>within 4 days after surgery</time_frame>
    <description>Visual Analogue Scale/Score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>the time of ambulation</measure>
    <time_frame>within 48 hours after surgery</time_frame>
    <description>the time after surgery that patients could leave the bed and walk</description>
  </primary_outcome>
  <primary_outcome>
    <measure>the time for oral feed</measure>
    <time_frame>within 48 hours after surgery</time_frame>
    <description>the time for oral feed</description>
  </primary_outcome>
  <primary_outcome>
    <measure>the time of hospitalization</measure>
    <time_frame>within 5 days after surgery</time_frame>
    <description>the time of hospitalization</description>
  </primary_outcome>
  <primary_outcome>
    <measure>complications</measure>
    <time_frame>within 7 days after surgery</time_frame>
    <description>the rate of complications</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>disease- free survival</measure>
    <time_frame>within 5 years after surgery</time_frame>
    <description>disease- free survival</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>overall survival</measure>
    <time_frame>within 10 years after surgery</time_frame>
    <description>overall survival</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Lung Cancer</condition>
  <condition>Surgery</condition>
  <condition>ERAS</condition>
  <arm_group>
    <arm_group_label>ERAS- Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients underwent surgery for lung cancer accepted the enhanced recovery after surgery (ERAS).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control- Group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients underwent surgery for lung cancer without enhanced recovery after surgery (ERAS).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Enhanced Recovery After Surgery (ERAS )</intervention_name>
    <description>the treatment of procedure according to Guidelines for enhanced recovery after lung surgery: recommendations of the ERAS Society and the ESTS</description>
    <arm_group_label>ERAS- Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Traditional perioperative management without Enhanced Recovery After Surgery (ERAS )</intervention_name>
    <description>the treatment of procedure not abiding Guidelines for enhanced recovery after lung surgery</description>
    <arm_group_label>Control- Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: patients with stage I-IIIa Non-small-cell Lung Cancer underwent radical
        resection.

        -

        Exclusion Criteria: cardio-pulmonary function couldn't tolerate surgery

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiaogang Zhao, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>The Second Hospital of Shandong University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yunpeng Zhao, Doctor</last_name>
    <phone>17660081916</phone>
    <phone_ext>17660081916</phone_ext>
    <email>zhaoyunpengsddx@sdu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Yunpeng Zhao</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250033</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yunpeng Zhao, Doc.</last_name>
      <phone>17660081916</phone>
      <phone_ext>17660081916</phone_ext>
      <email>zhaoyunpengsddx@sdu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 27, 2020</study_first_submitted>
  <study_first_submitted_qc>June 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 30, 2020</study_first_posted>
  <last_update_submitted>June 27, 2020</last_update_submitted>
  <last_update_submitted_qc>June 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

